sodium iodide [131i] injection ge healthcare 925 mbq/ ml
ge healthcare buchler gmbh & co. kg - natriumjodid (131i) - injeksjonsvæske, oppløsning - 925 mbq/ ml
sodium iodide [131i] injection ge healthcare 74 mbq/ ml
ge healthcare buchler gmbh & co. kg - natriumjodid (131i) - injeksjonsvæske, oppløsning - 74 mbq/ ml
sodium iodide [123i] capsules ge healthcare -
ge healthcare b.v. - natriumjodid (123i) - kapsel, hard
sodium iodide [123i] injection ge healthcare 37 mbq/ ml
ge healthcare b.v. - natriumjodid (123i) - injeksjonsvæske, oppløsning - 37 mbq/ ml
drytec tm -
ge healthcare b.v. - natriummolybdat mo-99 omdannes til natriumperteknetat tc-99m - radionuklidegenerator
nephromag 0.2 mg/2.5 ml
rotop pharmaka gmbh - mertiatid - preparasjonssett til radioaktive legemidler - 0.2 mg/2.5 ml
technescan mag3 1 mg
curium netherlands b.v. - betiatid - preparasjonssett til radioaktive legemidler - 1 mg
theracap 131tm -
ge healthcare buchler gmbh & co. kg - natriumjodid (131i) - kapsel, hard
nanocis 0.15 mg
cis bio international - rheniumsulfid - injeksjonsvæske, oppløsning - 0.15 mg
gavreto
roche registration gmbh - pralsetinib - karsinom, ikke-småcellet lunge - antineoplastiske midler - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.